CSat Investment Advisory’s Gilead Sciences GILD Stock Holding History

CSat Investment Advisory’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$10K	Buy	155 +39	+34%	+$2.52K	0.01%	451
2020 Q4	$7K	Sell	116 -6,891	-98%	-$416K	0.01%	458
2020 Q3	$442K	Buy	7,007 +898	+15%	+$62.3K	0.04%	185
2020 Q2	$470K	Buy	6,109 +1,545	+34%	+$118K	0.06%	192
2020 Q1	$341K	Buy	4,564 +1,962	+75%	+$136K	0.07%	178
2019 Q4	$169K	Buy	2,602 +902	+53%	+$58.7K	0.04%	257
2019 Q3	$108K	Buy	1,700 +192	+13%	+$12.6K	0.03%	302
2019 Q2	$101K	Buy	1,508 +1,451	+2,546%	+$95.5K	0.04%	297
2019 Q1	$4K	Buy	57 +8	+16%	+$532	﹤0.01%	518
2018 Q4	$3K	Buy	49 +20	+69%	+$1.4K	﹤0.01%	517
2018 Q3	$2K	Buy	29 +3	+12%	+$227	﹤0.01%	525
2018 Q2	$2K	Buy	+26	New	+$1.84K	﹤0.01%	527

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

CSat Investment Advisory's GILD Position: Q1 2021 in Review

CSat Investment Advisory increased its Gilead Sciences (GILD) stake by 34% in Q1 2021, buying an estimated $2.52K and bringing the position to 155 shares worth $10K. The position accounts for 0.01% of the portfolio, ranked #451.

CSat Investment Advisory first reported a position in GILD in Q2 2018 and has held it in 12 quarters since. The position peaked at $470K in Q2 2020. 1,568 funds tracked by Wall St. Rank hold GILD as of Q1 2021.

CSat Investment Advisory held 155 shares of Gilead Sciences worth $10K as of Q1 2021.
CSat Investment Advisory bought 39 Gilead Sciences shares in Q1 2021, an estimated $2.52K.
Gilead Sciences made up 0.01% of CSat Investment Advisory's portfolio in Q1 2021, its #451 holding.
CSat Investment Advisory first reported a position in Gilead Sciences in Q2 2018 and has held it in 12 quarters since.
CSat Investment Advisory's Gilead Sciences position peaked at $470K in Q2 2020.
1,568 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2021.

Based on CSat Investment Advisory's 13F filing for Q1 2021, filed 13 May 2021.